Condition: Major Depressive Disorder · Sponsor: Chonnam National University Hospital
The primary purpose of this study is to compare the short (12 week) and long-term (1-year) efficacy and the tolerability between stepwise psychopharmacotherapy and antidepressant monotherapy for 12 weeks in adult patients with major depressive disorders, stratified by the multimodal serum biomarker scores.
This description comes directly from the study's public registry record.
Jae-Min Kim, MD, PhD · 82-62-220-6043 · jmkim@chonnam.ac.kr
Hee-Ju Kang, MD, PhD · 82-62-220-5961 · hjkang82@chonnam.ac.kr
Always discuss trial participation with your own doctor first.
| Chonnam National University Hospital | Gwangju, South Korea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06054321